Nucleocapsid Protein as Early Diagnostic Marker for SARS


Serum samples from 317 patients with patients with severe acute respiratory syndrome (SARS) were tested for the nucleocapsid (N) protein of SARS-associated coronavirus, with sensitivities of 94% and 78% for the first 5 days and 6-10 days after onset, respectively. The specificity was 99.9%. N protein can be used as an early diagnostic maker for SARS.

Extracted Key Phrases

2 Figures and Tables


Citations per Year

103 Citations

Semantic Scholar estimates that this publication has 103 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Che2004NucleocapsidPA, title={Nucleocapsid Protein as Early Diagnostic Marker for SARS}, author={Xiao-yan Che and Wei Hao and Yadi Wang and B Di and Kai Yin and Yin-Chao Xu and Chang-Sen Feng and Zhuo-yue Wan and Vincent C.C. Cheng and Kwok-yung Yuen}, booktitle={Emerging infectious diseases}, year={2004} }